Math­ai Mam­men emerges as top can­di­date for Bio­gen CEO job — STAT

Two months af­ter his abrupt ex­it from J&J, Math­ai Mam­men is crop­ping up as a top can­di­date to suc­ceed Michel Vounatsos as Bio­gen’s next CEO, STAT re­port­ed.

Bio­gen an­nounced Vounatsos’ planned de­par­ture in May as the com­pa­ny reeled from the fall­out of re­strict­ed Medicare cov­er­age for Aduhelm, the Alzheimer’s drug that won a con­tro­ver­sial ap­proval at the FDA but flopped in the mar­ket, forc­ing a scale­down of the com­mer­cial roll­out and a painful re­struc­tur­ing. Cir­cum­stances, though, have since changed dra­mat­i­cal­ly, with Bio­gen and part­ners at Ei­sai re­cent­ly re­port­ing pos­i­tive da­ta for the fol­low-on Alzheimer’s drug lecanemab.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER